Gene · 8784
Papers4,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Revealing the molecular landscape of calcium oxalate renal calculi utilizing a tree shrew model: a transcriptomic analysis of the kidney. | Urolithiasis | 2024 | 39546021 | PubTator, text mining | PubMed |
| Phase I/II study of BMS-986156 with ipilimumab or nivolumab with or without stereotactic ablative radiotherapy in patients with advanced solid malignancies. | J Immunother Cancer | 2024 | 39384194 | PubTator, text mining | PubMed |
| Single-cell sequencing to multi-omics: technologies and applications. | Biomark Res | 2024 | 39334490 | PubTator, text mining | PubMed |
| TIGIT expression on neoplastic cells is a poor prognostic factor for adult T-cell leukaemia/lymphoma. | Pathology | 2024 | 39266421 | PubTator, text mining | PubMed |
| Acidity induces durable enhancement of Treg cell suppressive functions for tumor immune evasion. | Mol Immunol | 2024 | 39213947 | PubTator, text mining | PubMed |
| A disintegrin and metalloproteinase domain 10 expression inhibition by the small molecules adenosine, cordycepin and N6, N6-dimethyladenosine and immune regulation in malignant cancers. | Front Immunol | 2024 | 39211038 | PubTator, text mining | PubMed |
| Novel insights into immune checkpoints in psoriasis and atopic dermatitis: From expression and function to treatments. | Int Immunopharmacol | 2024 | 39079196 | PubTator, text mining | PubMed |
| Differential prognostic impact and potential molecular mechanisms of PCDHGA12 expression in lung adenocarcinoma and squamous cell carcinoma. | Int Immunopharmacol | 2024 | 39067405 | PubTator, text mining | PubMed |
| Exploring the Role of GITR/GITRL Signaling: From Liver Disease to Hepatocellular Carcinoma. | Cancers (Basel) | 2024 | 39061246 | PubTator, text mining | PubMed |
| Spatial Heterogeneity of Immune Regulators Drives Dynamic Changes in Local Immune Responses, Affecting Disease Outcomes in Pancreatic Cancer. | Clin Cancer Res | 2024 | 39007872 | PubTator, text mining | PubMed |
| Quantification and Profiling of Early and Late Differentiation Stage T Cells in Mantle Cell Lymphoma Reveals Immunotherapeutic Targets in Subsets of Patients. | Cancers (Basel) | 2024 | 39001353 | PubTator, text mining | PubMed |
| Immune checkpoint expression as prognostic biomarker candidates in non-small cell lung carcinoma patients. | J Surg Oncol | 2024 | 38973141 | PubTator, text mining | PubMed |
| Defining Human Regulatory T Cells beyond FOXP3: The Need to Combine Phenotype with Function. | Cells | 2024 | 38891073 | PubTator, text mining | PubMed |
| ABIN1 is a negative regulator of effector functions in cytotoxic T cells. | EMBO Rep | 2024 | 38877170 | PubTator, text mining | PubMed |
| GITR exacerbates lysophosphatidylcholine-induced macrophage pyroptosis in sepsis via posttranslational regulation of NLRP3. | Cell Mol Immunol | 2024 | 38740925 | PubTator, text mining | PubMed |
| Peripheral Soluble Immune Checkpoint-Related Proteins Were Associated with Survival and Treatment Efficacy of Osteosarcoma Patients, a Cohort Study. | Cancers (Basel) | 2024 | 38730580 | PubTator, text mining | PubMed |
| Transcriptomic analysis of GITR and GITR ligand reveals cancer immune heterogeneity with implications for GITR targeting. | Am J Cancer Res | 2024 | 38726288 | PubTator, text mining | PubMed |
| Multi-Omics profiling identifies aldehyde dehydrogenase 2 as a critical mediator in the crosstalk between Treg-mediated immunosuppression microenvironment and hepatocellular carcinoma. | Int J Biol Sci | 2024 | 38725845 | PubTator, text mining | PubMed |
| Expression patterns of novel immunotherapy targets in intermediate- and high-grade lung neuroendocrine neoplasms. | Cancer Immunol Immunother | 2024 | 38693435 | PubTator, text mining | PubMed |
| Generation of an Inhibitory NK Cell Subset by TGF-β1/IL-15 Polarization. | J Immunol | 2024 | 38668728 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8784/papers?page=8